Current approach es to the treatment of peritoneal pseudomyxoma of abdomen
- Authors: Abdullaev A.G1, Polotskiy B.E.1, Davydov M.I1
-
Affiliations:
- ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
- Issue: Vol 18, No 6 (2013)
- Pages: 4-11
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40000
- DOI: https://doi.org/10.17816/onco40000
- ID: 40000
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. G Abdullaev
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
Email: agulsky@rambler.ru
научн. сотр. отд-ния хирургического торакального 115448, г. Москва, Каширское шоссе, д.24
B. E. Polotskiy
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
M. I Davydov
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН
References
- Misdraji J., Yantiss R.K., Graeme-Cook F.M., Balis U.J., Young R.H. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am. J. Surg. Pathol. 2003; 27: 1089—103.
- Moran B.J., Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg. Oncol. Clin. N. Am. 2003; 12: 585—603.
- Nakakura E.K. Pseudomyxoma peritonei: more questions than answers. J. Clin. Oncol. 2012; 30(20): 2429—30.
- Carr N.J., Emory T.S., Sobin L.H. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2. Arch. Pathol. Lab. Med. 2002; 126: 837—41.
- Ronnett B.M., Zahn C.M., Kurman R.J., Kass M.E., Sugarbaker P.H., Shmookler B.M. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to “pseudomyxoma peritonei. Am. J. Surg. Pathol. 1995; 19: 1390—408.
- Chejfec G., Rieker W.J., Jablokow V.R., Gould V.E. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology. 1986; 90: 202—5.
- Hawes D., Robinson R., Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest. Radiol. 1991; 16: 80—2.
- Kahn M.A., Demopoulos R.I. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int. J. Gynecol. Pathol. 1992; 11: 15—23.
- Ronnett B.M., Seidman J.D. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am. J. Surg. Pathol. 2003; 27: 650—7.
- Carr N.J., Finch J., Ilesley I.C., Chandrakumaran K., Mohamed F., Mirnezami A., Cecil T., Moran B. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J. Clin. Pathol. 2012; 65(10): 919—23.
- Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Michigan: Ludann Company; 1998.
- Miner T.J., Shia J., Jaques D.P., Klimstra D.S., Brennan M.F., Coit D.G. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann. Surg. 2005; 241: 300—8.
- Chua T.C., Moran B.J., Sugarbaker P.H., Levine E.A., Glehen O., Gilly F.N. et al. Early- and long-term outcome data of patients with pseudomxyoma perontonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J. Clin. Oncol 2012; 30: 2449—56.
- Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduc-tion in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004; 240(2): 278—85.
- Elias D., Gilly F., Quenet F., Bereder J.M., Sidéris L., Mansvelt B., Lorimier G., Glehen O. Association Française de Chirurgie. Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur. J. Surg. Oncol. 2010; 36(5): 7.
- Elias D., Raynard B., Boige V., Laplanche A., Estphan G., Malka D., Pocard M. J. Impact of the extent and duration of cytore-ductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. Surg. Oncol. 2005; 90: 220—5.
- Glehen O., Cotte E., Brigand C., Arvieux C., Sayag-Beaujard A.C., Gilly F.N. Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: Cytoreductive surgery and intraperitoneal chemotherapy. Rev. Med. Int. 2006; 27: 382—91.
- Smeenk R.M., Verwaal VJ., Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur. J. Surg. Oncol. 2006; 32: 186—90.
- Сельчук В.Ю., Бычков М.Б., Киселевский М.В. Опухолевые серозиты: плевриты, асциты, перикардиты. М.: Практическая медицина; 2011: 214—9.
- Gilly F.N., Carry P.Y., Sayag A.C., Brachet A., Panteix G., Salle B. et al. Regional chemotherapy (with Mitomycic C) and intraoperative hyperthermia in abdominal cancer with peritoneal canceromatosis. Hepatogastroenterology. 1994; 41: 124—9.
- Kusamura S., Younan R., Baratti D., Costanzo P., Favaro M., Gavazzi C., Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: Analysis of morbidity and mortality in 209 cases treated with closed abdomen technique. Cancer. 2006; 106: 1144—53.
- Elias D., Matsuhisa T., Sideris L., Liberale G., Drouard-Troalen L., Raynard B. et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: Pharmacokinetics, tissue distribution and tolerance. Ann. Oncol. 2004; 1: 1558—65.
- Feldman L., Barkun J., Barkun A., Sampalis J., Rosenberg L. Measuring postoperative complications in general surgery patients using an outcomes-based strategy: Comparison with complications presented at morbidity and mortality rounds. Surgery. 1997; 122: P.711—9.
- Younan R., Kusamura S., Baratti D., Oliva G.D., Costanzo P., Favaro M., Gavazzi C., Deraco M. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonec-tomy and closed-technique intraperitoneal hyperthermic perfusion. Ann. Surg. Oncol. 2005; 12: 910—8.
- Tsilimparis N., Bockelmann C., Raue W., Menenakos C., Perez S., Rau B., Hartmann J. Quality of life in patients after cytoreduc-tive surgery and hyperthermic intraperitoneal chemotherapy: Is it worth the risk? Ann. Surg. Oncol. 2012
- Los G., Sminia P., Wondergem J. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur. J. Cancer. 1991; 27: 472—7.
Supplementary files
